- Home
- RGEN vs EXP Comparison
RGEN vs EXP Comparison
Compare RGEN & EXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RGEN
- EXP
- Stock Information
- Founded
- RGEN 1981
- EXP 1963
- Country
- RGEN United States
- EXP United States
- Employees
- RGEN N/A
- EXP N/A
- Industry
- RGEN Medical/Dental Instruments
- EXP Building Materials
- Sector
- RGEN Health Care
- EXP Industrials
- Exchange
- RGEN Nasdaq
- EXP Nasdaq
- Market Cap
- RGEN 8.0B
- EXP 7.3B
- IPO Year
- RGEN N/A
- EXP 1994
- Fundamental
- Price
- RGEN $126.50
- EXP $240.02
- Analyst Decision
- RGEN Buy
- EXP Buy
- Analyst Count
- RGEN 12
- EXP 11
- Target Price
- RGEN $172.67
- EXP $275.45
- AVG Volume (30 Days)
- RGEN 815.5K
- EXP 278.7K
- Earning Date
- RGEN 04-29-2025
- EXP 05-20-2025
- Dividend Yield
- RGEN N/A
- EXP 0.42%
- EPS Growth
- RGEN N/A
- EXP N/A
- EPS
- RGEN N/A
- EXP 13.93
- Revenue
- RGEN $650,429,000.00
- EXP $2,267,040,000.00
- Revenue This Year
- RGEN $13.93
- EXP $1.49
- Revenue Next Year
- RGEN $14.35
- EXP $4.58
- P/E Ratio
- RGEN N/A
- EXP $17.20
- Revenue Growth
- RGEN 4.88
- EXP 0.64
- 52 Week Low
- RGEN $102.97
- EXP $201.61
- 52 Week High
- RGEN $182.52
- EXP $321.93
- Technical
- Relative Strength Index (RSI)
- RGEN 44.61
- EXP 61.02
- Support Level
- RGEN $123.10
- EXP $231.79
- Resistance Level
- RGEN $135.47
- EXP $241.89
- Average True Range (ATR)
- RGEN 6.98
- EXP 6.48
- MACD
- RGEN -0.97
- EXP 1.20
- Stochastic Oscillator
- RGEN 25.20
- EXP 92.51
About RGEN Repligen Corporation
Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.
About EXP Eagle Materials Inc
Eagle Materials Inc produces and sells construction products and building materials. Construction products include cement, slag, concrete, and aggregates and building materials include cement and gypsum wallboard, and are sold to the construction and building industries. The firm organizes itself into two sectors: Heavy Materials, which includes the Cement and Concrete and Aggregates segments, and Light Materials, which includes the Gypsum Wallboard and Recycled Paperboard segments.